KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teleflex (TFX) Gains from Sales and Divestitures (2011 - 2013)

Teleflex posted quarterly Gains from Sales and Divestitures of $99666.0 for Q4 2013, up 26.56% year-on-year from $78753.0 in Q4 2012, and up 26.56% on a QoQ basis from $78753.0 in Q4 2012.

Teleflex (TFX) has 3 years of Gains from Sales and Divestitures data on file, last reported at $99666.0 in Q4 2013.

  • For the quarter ending Q4 2013, Gains from Sales and Divestitures rose 26.56% year-over-year to $99666.0; the trailing twelve-month figure through Dec 2013 stood at $99666.0 (up 26.56% YoY), and the FY2013 full-year result was $99666.0, up 26.56% from the prior year.
  • Gains from Sales and Divestitures for Q4 2013 stood at $99666.0, up from $78753.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $99666.0 in Q4 2013 and bottomed at $78753.0 in Q4 2012.
  • The 3-year median for Gains from Sales and Divestitures is $90508.0 (2011), against an average of $89642.3.
  • The widest annual swing landed in 2012, when Gains from Sales and Divestitures slipped 12.99%; it then gained 26.56% in 2013.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $90508.0 in 2011, then retreated by 12.99% to $78753.0 in 2012, then rose by 26.56% to $99666.0 in 2013.
  • The last three Gains from Sales and Divestitures figures came in at $99666.0 (Q4 2013), $78753.0 (Q4 2012), and $90508.0 (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Teleflex 5.83 Bn 5.52 Bn 307.43 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2013 99,666.00
Dec 31, 2013 99,666.00
Dec 31, 2012 78,753.00
Dec 31, 2012 78,753.00
Dec 31, 2011 90,508.00
Dec 31, 2011 90,508.00